Children on Antipsychotics 50% More Likely to Develop Diabetes
Antipsychotic drugs increased the risk of children developing diabetes by 50%, and with an antidepressant added, their risk doubled.
When university attorneys play hardball with patients
Everyone knows that some attorneys have a reputation for playing hardball. In fact, many of us even seek out attorneys who play hardball. But...
Health Care? More Like Health Scare!
From the Lown Institute: For pharmaceutical companies who use scare tactics to sell drugs, every day is like Halloween. This list of egregious advertisements shows...
Markingson Case Supporters: Please Join Our Call-In Campaign
Patient advocates and bioethicists have launched a call-in campaign demanding action on psychiatric research abuse at the University of Minnesota.
Many Psychiatric Patients Sent Home With Multiple Antipsychotics Against Guidelines
Despite the fact that clinical practice guidelines specifically recommend against the use of more than one antipsychotic at once, new research reveals that as...
Most Preschoolers with ADHD Stay on Meds for Years
About 65% of preschool children who were diagnosed with ADHD and given stimulant drugs were still taking those drugs six years later.
Antipsychotics Not Helpful for Anorexia
A review of all research on the use of antipsychotics for the treatment of anorexia nervosa found no demonstrable efficacy in terms of body...
“When Does That Go On Trial?”
1 Boring Old Man scrutinizes the evidence that Johnson & Johnson hid evidence of Risperdal's breast-growing properties, among other improper actions, concluding "The story...
The Road to Perdition
The recent research scandals out of the University of Minnesota’s Department of Psychiatry may be alarming, but they are not new. Back in the 1990s, when the university was working its way towards a crippling probation by the National Institutes of Health (for yet another episode of misconduct (this time in the Department of Surgery), the Department of Psychiatry hosted two spectacular cases of research wrongdoing, both of which resulted in faculty members being disqualified from conducting research by the FDA.
Researchers Struggle as Placebos Becoming More Effective & Antipsychotics Losing Power
Since the 1960s, the positive response rates to antipsychotic medications have been dropping steadily, according to a meta-analysis published in JAMA Psychiatry by Columbia...
Social Support Improves Antipsychotic Discontinuation, Study Finds
A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.
Nutrient Supplementation Improves Outcomes for Patients Diagnosed with Schizophrenia
A review article and meta-analysis of 18 articles published in the journal of Psychological Medicine reported effects of vitamin and/or mineral supplements on psychiatric symptoms in people diagnosed with schizophrenia. The study provides evidence of the beneficial effects of taking certain vitamins and minerals for improving symptoms associated with schizophrenia.
The Once and Future Abilify: Depot Injections for Everyone?
This column is partly a report on the marketing of Abilify, the atypical antipsychotic that has become America’s best-selling drug. It’s also an appeal for advice and feedback from the RxISK and Mad in America communities, and a call for some brainstorming about strategy. The plans laid out by drugmakers Otsuka and Lundbeck for Abilify’s future, and the cooperation they’re getting from leading universities, are alarming enough to me that reporting on them seems inadequate. We need action, although I’m not sure exactly what kind.
Study Challenges Assumption that Schizophrenia Impairs Cognitive Ability
Secondary factors may impair performance on cognitive tasks, making it difficult for individuals diagnosed with schizophrenia to perform to the best of their ability.
Antipsychotics Aren’t Helpful to Children
Researchers from London, writing in European Psychiatry, reviewed "all RCTs involving children and young people with a diagnosis of childhood onset schizophrenia comparing any...
Olanzapine Can Cause Serious Skin Reaction, FDA Warns
The US FDA has issued a new warning for the atypical antipsychotic Olanzapine, also known by the brand names Zyprexa and Symbyax. The agency...
Neuroleptic Drugs: Patient vs. Provider Perspective
In January 2012, The Journal of Social Psychiatry and Psychiatric Epidemiology published a study which suggests that providers who prescribe neuroleptics are unaware of how impacted their patients are by the adverse effects of these drugs. Now more than ever we need to reevaluate the benefits and harms that can come with psychiatric drugs. The power inherent in this kind of practice -- exercising a marginalized voice or tending to our mistakes -- is the very essence of healing.
Temperature-Related Deaths in People with Mental Illness
Writing in the British Journal of Psychiatry, English researchers found that "patients with mental illness showed an overall increase in risk of death of...
Negative Symptoms Predict Quality of Life
Researchers assessed 55 first-episode drug-naive people with schizophrenia diagnoses in New Delhi, India for the predictive value of symptoms on quality of life (QOL)....
Antipsychotics Associated with High Risk of Death in Children
A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.
Curing Schizophrenia via Intensive Psychotherapy
I believe that an Intensive Psychotherapy can lead to healing and, often, a cure of psychotic states. By cure I mean the cessation of delusions and hallucinations, and a gradual titration off of antipsychotic medication, with the cure lasting—even without continuing psychotherapy.
New Research Suggests Brain Abnormalities in ‘Schizophrenia’ May Result From Antipsychotics
Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.
Significant Growth of Antipsychotics Market Foreseen
From Persistent Market Research: The global antipsychotics market is expected to grow significantly by 2021, with especially high growth rates in Europe and Asia. However,...